Literature DB >> 33402705

FOXP1 negatively regulates intrinsic excitability in D2 striatal projection neurons by promoting inwardly rectifying and leak potassium currents.

Sheridan Cavalier1, Volodymyr Rybalchenko1, Nitin Khandelwal1, Ashwinikumar Kulkarni1, Ashley G Anderson1, Genevieve Konopka2, Jay R Gibson3.   

Abstract

Heterozygous loss-of-function mutations in the transcription factor FOXP1 are strongly associated with autism. Dopamine receptor 2 expressing (D2) striatal projection neurons (SPNs) in heterozygous Foxp1 (Foxp1+/-) mice have higher intrinsic excitability. To understand the mechanisms underlying this alteration, we examined SPNs with cell-type specific homozygous Foxp1 deletion to study cell-autonomous regulation by Foxp1. As in Foxp1+/- mice, D2 SPNs had increased intrinsic excitability with homozygous Foxp1 deletion. This effect involved postnatal mechanisms. The hyperexcitability was mainly due to down-regulation of two classes of potassium currents: inwardly rectifying (KIR) and leak (KLeak). Single-cell RNA sequencing data from D2 SPNs with Foxp1 deletion indicated the down-regulation of transcripts of candidate ion channels that may underlie these currents: Kcnj2 and Kcnj4 for KIR and Kcnk2 for KLeak. This Foxp1-dependent regulation was neuron-type specific since these same currents and transcripts were either unchanged, or very little changed, in D1 SPNs with cell-specific Foxp1 deletion. Our data are consistent with a model where FOXP1 negatively regulates the excitability of D2 SPNs through KIR and KLeak by transcriptionally activating their corresponding transcripts. This, in turn, provides a novel example of how a transcription factor may regulate multiple genes to impact neuronal electrophysiological function that depends on the integration of multiple current types - and do this in a cell-specific fashion. Our findings provide initial clues to altered neuronal function and possible therapeutic strategies not only for FOXP1-associated autism but also for other autism forms associated with transcription factor dysfunction.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33402705      PMCID: PMC8255328          DOI: 10.1038/s41380-020-00995-x

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   13.437


  49 in total

1.  FOXP1-related intellectual disability syndrome: a recognisable entity.

Authors:  Ilse Meerschaut; Daniel Rochefort; Nicole Revençu; Justine Pètre; Christina Corsello; Guy A Rouleau; Fadi F Hamdan; Jacques L Michaud; Jenny Morton; Jessica Radley; Nicola Ragge; Sixto García-Miñaúr; Pablo Lapunzina; Maria Palomares Bralo; Maria Ángeles Mori; Stéphanie Moortgat; Valérie Benoit; Sandrine Mary; Nele Bockaert; Ann Oostra; Olivier Vanakker; Milen Velinov; Thomy Jl de Ravel; Djalila Mekahli; Jonathan Sebat; Keith K Vaux; Nataliya DiDonato; Andrea K Hanson-Kahn; Louanne Hudgins; Bruno Dallapiccola; Antonio Novelli; Luigi Tarani; Joris Andrieux; Michael J Parker; Katherine Neas; Berten Ceulemans; An-Sofie Schoonjans; Darina Prchalova; Marketa Havlovicova; Miroslava Hancarova; Magdalena Budisteanu; Annelies Dheedene; Björn Menten; Patrick A Dion; Damien Lederer; Bert Callewaert
Journal:  J Med Genet       Date:  2017-07-22       Impact factor: 6.318

2.  Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain.

Authors:  Russell J Ferland; Timothy J Cherry; Patricia O Preware; Edward E Morrisey; Christopher A Walsh
Journal:  J Comp Neurol       Date:  2003-05-26       Impact factor: 3.215

3.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism.

Authors:  F Kyle Satterstrom; Jack A Kosmicki; Jiebiao Wang; Michael S Breen; Silvia De Rubeis; Joon-Yong An; Minshi Peng; Ryan Collins; Jakob Grove; Lambertus Klei; Christine Stevens; Jennifer Reichert; Maureen S Mulhern; Mykyta Artomov; Sherif Gerges; Brooke Sheppard; Xinyi Xu; Aparna Bhaduri; Utku Norman; Harrison Brand; Grace Schwartz; Rachel Nguyen; Elizabeth E Guerrero; Caroline Dias; Catalina Betancur; Edwin H Cook; Louise Gallagher; Michael Gill; James S Sutcliffe; Audrey Thurm; Michael E Zwick; Anders D Børglum; Matthew W State; A Ercument Cicek; Michael E Talkowski; David J Cutler; Bernie Devlin; Stephan J Sanders; Kathryn Roeder; Mark J Daly; Joseph D Buxbaum
Journal:  Cell       Date:  2020-01-23       Impact factor: 41.582

4.  No neural evidence of statistical learning during exposure to artificial languages in children with autism spectrum disorders.

Authors:  Ashley A Scott-Van Zeeland; Kristin McNealy; A Ting Wang; Marian Sigman; Susan Y Bookheimer; Mirella Dapretto
Journal:  Biol Psychiatry       Date:  2010-03-29       Impact factor: 13.382

5.  Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci.

Authors:  Stephan J Sanders; Xin He; A Jeremy Willsey; A Gulhan Ercan-Sencicek; Kaitlin E Samocha; A Ercument Cicek; Michael T Murtha; Vanessa H Bal; Somer L Bishop; Shan Dong; Arthur P Goldberg; Cai Jinlu; John F Keaney; Lambertus Klei; Jeffrey D Mandell; Daniel Moreno-De-Luca; Christopher S Poultney; Elise B Robinson; Louw Smith; Tor Solli-Nowlan; Mack Y Su; Nicole A Teran; Michael F Walker; Donna M Werling; Arthur L Beaudet; Rita M Cantor; Eric Fombonne; Daniel H Geschwind; Dorothy E Grice; Catherine Lord; Jennifer K Lowe; Shrikant M Mane; Donna M Martin; Eric M Morrow; Michael E Talkowski; James S Sutcliffe; Christopher A Walsh; Timothy W Yu; David H Ledbetter; Christa Lese Martin; Edwin H Cook; Joseph D Buxbaum; Mark J Daly; Bernie Devlin; Kathryn Roeder; Matthew W State
Journal:  Neuron       Date:  2015-09-23       Impact factor: 17.173

6.  The contribution of de novo coding mutations to autism spectrum disorder.

Authors:  Ivan Iossifov; Brian J O'Roak; Stephan J Sanders; Michael Ronemus; Niklas Krumm; Dan Levy; Holly A Stessman; Kali T Witherspoon; Laura Vives; Karynne E Patterson; Joshua D Smith; Bryan Paeper; Deborah A Nickerson; Jeanselle Dea; Shan Dong; Luis E Gonzalez; Jeffrey D Mandell; Shrikant M Mane; Michael T Murtha; Catherine A Sullivan; Michael F Walker; Zainulabedin Waqar; Liping Wei; A Jeremy Willsey; Boris Yamrom; Yoon-ha Lee; Ewa Grabowska; Ertugrul Dalkic; Zihua Wang; Steven Marks; Peter Andrews; Anthony Leotta; Jude Kendall; Inessa Hakker; Julie Rosenbaum; Beicong Ma; Linda Rodgers; Jennifer Troge; Giuseppe Narzisi; Seungtai Yoon; Michael C Schatz; Kenny Ye; W Richard McCombie; Jay Shendure; Evan E Eichler; Matthew W State; Michael Wigler
Journal:  Nature       Date:  2014-10-29       Impact factor: 69.504

7.  Brain-specific Foxp1 deletion impairs neuronal development and causes autistic-like behaviour.

Authors:  C Bacon; M Schneider; C Le Magueresse; H Froehlich; C Sticht; C Gluch; H Monyer; G A Rappold
Journal:  Mol Psychiatry       Date:  2014-09-30       Impact factor: 15.992

8.  Prospective investigation of FOXP1 syndrome.

Authors:  Paige M Siper; Silvia De Rubeis; Alexander Kolevzon; Joseph D Buxbaum; Maria Del Pilar Trelles; Allison Durkin; Daniele Di Marino; François Muratet; Yitzchak Frank; Reymundo Lozano; Evan E Eichler; Morgan Kelly; Jennifer Beighley; Jennifer Gerdts; Arianne S Wallace; Heather C Mefford; Raphael A Bernier
Journal:  Mol Autism       Date:  2017-10-24       Impact factor: 7.509

9.  FoxP1 orchestration of ASD-relevant signaling pathways in the striatum.

Authors:  Daniel J Araujo; Ashley G Anderson; Stefano Berto; Wesley Runnels; Matthew Harper; Simon Ammanuel; Michael A Rieger; Hung-Chung Huang; Kacey Rajkovich; Kristofer W Loerwald; Joseph D Dekker; Haley O Tucker; Joseph D Dougherty; Jay R Gibson; Genevieve Konopka
Journal:  Genes Dev       Date:  2015-10-15       Impact factor: 11.361

10.  Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.

Authors:  Holly A F Stessman; Bo Xiong; Bradley P Coe; Tianyun Wang; Kendra Hoekzema; Michaela Fenckova; Malin Kvarnung; Jennifer Gerdts; Sandy Trinh; Nele Cosemans; Laura Vives; Janice Lin; Tychele N Turner; Gijs Santen; Claudia Ruivenkamp; Marjolein Kriek; Arie van Haeringen; Emmelien Aten; Kathryn Friend; Jan Liebelt; Christopher Barnett; Eric Haan; Marie Shaw; Jozef Gecz; Britt-Marie Anderlid; Ann Nordgren; Anna Lindstrand; Charles Schwartz; R Frank Kooy; Geert Vandeweyer; Celine Helsmoortel; Corrado Romano; Antonino Alberti; Mirella Vinci; Emanuela Avola; Stefania Giusto; Eric Courchesne; Tiziano Pramparo; Karen Pierce; Srinivasa Nalabolu; David G Amaral; Ingrid E Scheffer; Martin B Delatycki; Paul J Lockhart; Fereydoun Hormozdiari; Benjamin Harich; Anna Castells-Nobau; Kun Xia; Hilde Peeters; Magnus Nordenskjöld; Annette Schenck; Raphael A Bernier; Evan E Eichler
Journal:  Nat Genet       Date:  2017-02-13       Impact factor: 38.330

View more
  3 in total

1.  Coordinated postnatal maturation of striatal cholinergic interneurons and dopamine release dynamics in mice.

Authors:  Avery McGuirt; Michael Post; Irena Pigulevskiy; David Sulzer; Ori Lieberman
Journal:  J Neurosci       Date:  2021-03-04       Impact factor: 6.167

Review 2.  Molecular Pathophysiological Mechanisms in Huntington's Disease.

Authors:  Anamaria Jurcau
Journal:  Biomedicines       Date:  2022-06-17

Review 3.  Structural and Functional Aspects of the Neurodevelopmental Gene NR2F1: From Animal Models to Human Pathology.

Authors:  Chiara Tocco; Michele Bertacchi; Michèle Studer
Journal:  Front Mol Neurosci       Date:  2021-12-15       Impact factor: 5.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.